- Report
- October 2024
- 184 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 94 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- July 2023
- 104 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- July 2023
- 112 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
Calcium Alginate is a type of hematological drug used to treat a variety of blood-related disorders. It is a polysaccharide derived from seaweed and is used to form a gel-like substance when mixed with calcium ions. This gel-like substance is used to treat conditions such as thrombocytopenia, anemia, and hemophilia. It is also used to reduce the risk of bleeding in patients with clotting disorders. Calcium Alginate is also used to treat iron deficiency anemia, as it helps to increase the absorption of iron in the body.
The Calcium Alginate market is a rapidly growing sector of the hematological drugs market. It is used in a variety of applications, from treating blood-related disorders to reducing the risk of bleeding in patients with clotting disorders. The market is expected to continue to grow as more applications are discovered and developed.
Some companies in the Calcium Alginate market include Merck, Pfizer, Novartis, and Sanofi. Show Less Read more